Custom High-Loading EGCG Nanoparticles Development Service for Enhanced Combination Antitumor Therapy

0
6

Natural products have great potential in biomedical research, drug development and clinical applications as they can be used medicinal sources to treat cancer, bacterial and fungal infections, inflammation and other diseases. These compounds in particular exhibit excellent biocompatibility, broad-spectrum biological activity and highly targeted effects, making them potent anti-cancer chemopreventive and chemotherapeutic agents with minimal side effects. Furthermore, these abundant and diverse natural sources can help to reduce the cost of cancer treatment.

EGCG is a natural phenolic compound found in foods and beverages (particularly tea) that exhibits a wide range of biological activities, including antioxidant, antibacterial, anti-obesity, anti-inflammatory and anticancer properties. The formation of EGCG self-assembled nanoparticles (ENPs) during the oxidation process is driven by intermolecular interactions, which maintain the stability of the nanoparticles. EGCG-based nanoparticles are an excellent carrier platform for antitumour drug delivery. To support researchers' work, CD Bioparticles now offers a high-loading EGCG-based nanoparticle platform designed specifically for combined antitumour therapy and efficient drug delivery.

CD Bioparticles offers custom, high-loading EGCG nanoparticle services to leverage advanced nanomedicine delivery technologies to achieve high loading, controlled release and targeted delivery, thereby maximizing the therapeutic potential of EGCG. The platform achieves loading rates of 30–50% (compared to 5–10% for traditional carriers), thereby increasing the effective dose while reducing the required carrier amount.

Additionally, the platform offers broad drug compatibility and is capable of simultaneously loading both hydrophilic and hydrophobic drugs, providing an efficient platform for multi-drug combination therapy. CD Bioparticles supports anti-tumour combination therapy regimens to achieve drug synergy and improve treatment outcomes. With a particle size range of 100–200 nm, CD Bioparticles' nanoparticles enhance tumour permeability and cellular uptake.

CD Bioparticles' comprehensive services include nanoparticle preparation customization, drug loading and capacity optimization, precise particle size and morphology characterization, stability and release performance evaluation, biocompatibility and efficacy assessment, and scalable production. These services can support researchers in various applications, such as in vitro drug screening and delivery mechanism studies, antitumour combination drug delivery, and targeted drug delivery and nanomedicine development.

Researchers and pharmaceutical developers working in oncology, targeted nanomedicine and sustained-release systems R&D who would like to learn more about CD Bioparticles' High-Loading-Capacity EGCG Nanoparticle Development services, or who would like to discuss custom project requirements and explore available development solutions, please visit https://www.cd-bioparticles.net/services/custom-high-loading-egcg-nanoparticles-development-service.html.

About CD Bioparticles

CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.

Site içinde arama yapın
Kategoriler
Read More
Health
Global Sugar Sphere Market Size and Revenue Prospects at 6.34% CAGR
The global sugar sphere market is experiencing steady growth, supported by increasing demand for...
By Adam Winter 2026-11-12 14:41:10 0 140
Other
Global Spinal Implants Market Valuation to Reach US$ 19.34 Billion by 2031, Registering a 105.5% CAGR
The Spinal Implants Market is expanding as medical device manufacturers, healthcare systems,...
By Monica Scott 2026-11-19 14:22:58 0 6
Other
Virtual Private Server Market Value Through Security and Cost Efficiency
The Virtual Private Server Market Size is experiencing significant expansion, driven by the...
By Akankshs Bhoie 2026-10-23 16:13:44 0 310
Other
PW Consulting: Polymer Reinforcing Filler market hits USD 14,250.6M in 2025; 5.5% CAGR to 2032, Asia Pacific USD 6,394M leader
Polymer Reinforcing Filler Market — Strategic Preview for 2026 Decision-Makers PW...
By Ryan Lee 2026-08-28 11:54:50 0 280
Other
PW Consulting: Plastic Roof Cement Market valued at USD 945.5M in 2025; 4.85% CAGR projected 2026–2032
Plastic Roof Cement Market: Strategic Imperatives for 2026 — PW Consulting Launches...
By Ryan Lee 2026-08-28 09:37:58 0 228